Cure My Disease

Don't miss your cure!

 Log in / Sign up

New laser blood test aims to detect breast cancer earlier

NCT ID NCT04273542

Ongoing Diagnosis Sponsor: Centre Jean Perrin Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This large study is testing whether a new laser-based blood test can help screen for breast cancer. Researchers will compare blood samples from women with and without breast cancer to see if the test can accurately spot the disease. If it works, it could offer a less invasive way to screen for breast cancer alongside mammograms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liquid biopsy (blood sample)
What this could lead to
If successful, this could lead to a simple blood test that helps detect breast cancer earlier, potentially reducing the need for some mammograms.
What could go wrong
This is a validation study, not a treatment trial. The new laser technique is still experimental and may not prove accurate enough to replace current screening methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

BRCA1-related cancer predisposition BRCA2-related cancer predisposition breast carcinoma in situ breast neoplasm female breast carcinoma invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRCA1 MUTATION BRCA2 MUTATION BREAST CANCER FEMALE

Contacts and locations

Locations

  • Centre Eugène MARQUIS

    Rennes, France

  • Centre Jean PERRIN

    Clermont-Ferrand, Puy de Dome, 63011, France

  • Hôpital La Pitié Salpêtrière

    Paris, Île-de-France Region, 75000, France

  • Hôpital Saint-Louis

    Paris, Île-de-France Region, 75010, France

  • Hôpital Tenon

    Paris, Île-de-France Region, 75020, France

  • Institut de Cancérologie de l'Ouest

    Angers, France

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, France

  • La Chataigneraie (Selimed 63)

    Beaumont, Puy de Dôme, 63110, France

  • Pôle Santé République

    Clermont-Ferrand, Puy de Dôme, 63000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.